» Articles » PMID: 17362440

Acute Confusional State After Designer Tryptamine Abuse

Overview
Specialties Neurology
Psychiatry
Date 2007 Mar 17
PMID 17362440
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

A 23-year-old Japanese woman was brought to the emergency department about 6.5 h after taking liquid and later a half tablet purchased on the street. About 4.5 h prior to presentation, she displayed excited and disorganized behavior. On examination, she was not alert or oriented, with a Glasgow Coma Scale score of 13, did not answer any questions from doctors while smirking and looking around restlessly, and sometimes exhibited echolalia, imitating the speech of doctors. She was given intravenous infusion of fluid for 8 h, then discharged. Gas chromatography-mass spectrometry of urine revealed 5-methoxy-diisopropyltryptamine, 5-methoxy-N-methyltryptamine and an unidentified tryptamine. Identifying chemical products based solely on information of users is insufficient, and urinalysis is necessary in cases potentially involving designer drugs.

Citing Articles

Pharmaco-toxicological effects of the novel tryptamine hallucinogen 5-MeO-MiPT on motor, sensorimotor, physiological, and cardiorespiratory parameters in mice-from a human poisoning case to the preclinical evidence.

Bassi M, Bilel S, Tirri M, Corli G, Di Rosa F, Gregori A Psychopharmacology (Berl). 2024; 241(3):489-511.

PMID: 38214743 PMC: 10884077. DOI: 10.1007/s00213-024-06526-8.


Dual actions of 5-MeO-DIPT at the serotonin transporter and serotonin 5-HT receptor in the mouse striatum and prefrontal cortex.

Hagino Y, Hall F, Uhl G, Sora I, Ikeda K Neuropsychopharmacol Rep. 2021; 41(1):91-101.

PMID: 33547882 PMC: 8182963. DOI: 10.1002/npr2.12161.


Designer drugs: mechanism of action and adverse effects.

Luethi D, Liechti M Arch Toxicol. 2020; 94(4):1085-1133.

PMID: 32249347 PMC: 7225206. DOI: 10.1007/s00204-020-02693-7.


Prolonged delusional state triggered by repeated ingestion of aromatic liquid in a past 5-methoxy-N, N-diisopropyltryptamine abuser.

Fuse-Nagase Y, Nishikawa T Addict Sci Clin Pract. 2013; 8(1):9.

PMID: 23577618 PMC: 3637077. DOI: 10.1186/1940-0640-8-9.